Results 191 to 191 of about 5,337 (191)

TRAILBLAZER‐ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's disease

Alzheimer's and Dementia
exaly